A Synergetic Role Of 1,25-Dihydroxyvitamin D-3 In 17 Beta-Estradial Induced-Proliferation And Differentiation Of Osteoblastic Mc3t3-E1 Cells
Lige Song,Xiuzhen Zhang,Yun Zhou
DOI: https://doi.org/10.1016/j.ejphar.2011.01.003
IF: 5.195
2011-01-01
European Journal of Pharmacology
Abstract:Although the effect of 17 beta-estradial, a polyphenolic phytoestrogen, on bone cell function has been studied in numerous cell models, the synergetic role of 1, 25-dihydroxyvitamin D-3 on 17 beta-estradial induced-proliferation and differentiation of osteoblastic cells, and the underlying mechanism are obscure. Here, we investigated the in vitro effect of 17 beta-estradial on cell proliferation and osteoblastic maturation in MC3T3-E1 cells. 17 beta-estradial could promote the proliferation and viability of MC3T3-E1 cells, associated with upregulation of cyclin E and proliferation cell nuclear antigen (PCNA) mRNA expression, and downregulation of cyclin-dependent kinase inhibitor 2b (Cdkn2b) mRNA expression. Moreover, 17 beta-estradial also could stimulate osteoblastic differentiation and bone formation as assessed by alkaline phosphatase (ALP) and Alizarin Red S staining, through induction of the expression of osteoblastic markers, including ALP, osteopontin and type I collagen in MC3T3-E1 cells. However, 1,25-dihydroxyvitamin D-3 treatment alone showed no effect on proliferation and differentiation of MC3T3-E1 cells, but could coordinately augment effects of 17 beta-estradial on MC3T3-E1 cells. The mechanism conducted demonstrated that 17 beta-estradial activated ERK1/2 but not JNK and p38, and U0126, an ERK1/2 pathway inhibitor, significantly downregulated vitamin D receptor expression induced by 17 beta-estradial in MC3T3-E1 cells. Thus, our data demonstrated a synergistical role of 1,25-dihydroxyvitamin 03 and 17 beta-estradial in proliferation and differentiation of osteoblasts, and this coordinated regulation might depend on the upregulation of vitamin D receptor in osteoblasts by 17 beta-estradial. Moreover, during the process of vitamin D receptor upregulation by 17 beta-estradial, ERK1/2 signaling is involved. (C) 2011 Elsevier B.V. All rights reserved.